Blogs

Chris Molloy on what the new Government means for the sector, a farewell to Lord Patrick Vallance, gene synthesis screening and TechBio UK early bird tickets

From first-in-class approvals to billion-dollar deals, Q2 2026 signals a new era for antibody innovation

Chris Molloy on the Q2 2026 finance report, investment in Draig Therapeutics, MHRA meeting, centure capital summit and upcoming BIA events

Solena Materials is a pioneering biotech company specialising in computationally-designed synthetic protein materials

How to unlock the UK's innovative life sciences and biotech potential

Jane Wall discusses investment in Alchemab Therapeutics, Life Sciences Sector Plan: one year on, regulatory and trade links, Women in Biotech and BIA members lounge

How we boost entry-level diversity up to the senior level

Discover how BIA members influenced the UK Life Sciences Sector Jobs Plan, addressing critical biotech talent shortages, lab skills and AI innovation

Each month, our Policy and Public Affairs team will showcase how we are championing members’ voices in Government and Parliament.

Chris Molloy on scale-up policy, improving treatments pipeline, LSSP, GMM regulation, LLSW, MDUK's Pedal Paddle Peak and Dr Sally Ann Forsyth OBE

Key takeaways as another BIA Summer Party 2026 delivers for the life sciences sector

The Global Talent visa route has been made easier for research-intensive businesses to attract international researchers and specialists

We must engage with the Chinese ecosystem – this is how

BIO Convention, RQ Bio’s oversubscribed Series A, BIA Summer Party, expanding overseas webinar and BIA BD vacancy

Looking back at the TechBio X event at Cambridge Wide Open Week

BIO 2026, UK-China relations, EU biosolutions, TechBio X, expanding overseas and BIA Summer Party

A pipeline of encouraging funding opportunities for the engineering biology community

The challenges businesses must address to mitigate risk and ensure seamless compliance

New AI infrastructure, the MHRA AI Sandbox, life science leadership, global advocacy and BIA’s upcoming events

The challenge of converting scientific progress into real-world access